Search results for: staining
#32084662 // Save this To Up
The preparation of cell-containing microbubble scaffolds to mimic alveoli structure as 3D drug screening system for lung cancer.Cancer is the leading cause of mortality worldwide, and lung cancer is the most malignant. However, the high failure rate in oncology drug development from in vitro studies to in vivo preclinical models indicates that the modern methods of evaluating drug efficacies in vitro are not reliable. Traditional 2-dimensional (2D) cell culture has been proved inadequate to mimic real physiological conditions. Current 3-dimensional (3D) cell culture methods do not represent the delicate structure of lung alveoli. To mimic lung alveoli structure, a cell containing enzyme-cross-linked gelatin microbubble scaffold was produced by mixing surfactant-containing gelatin solution with microbial transglutaminase (mTGase)-mixed A549 cell suspension in a four-channel flow focusing microfluidic device. With uniform pore size of about 100 μm in diameter, this gelatin microbubble scaffold resembled the lung alveoli in structure and in mechanical properties with good biocompatibility. Effective gemcitabine concentration required to induce cell death in microbubble scaffolds was significantly higher than in 2D culture together with a longer treatment time. Cell death mechanisms were confirmed to be gemcitabine-induced cell apoptosis through Western blotting and real-time PCR. H&E staining and TUNEL assay showed rounded cells with DNA damage in drug-treated scaffolds. Taken together, the cell-containing microbubble scaffolds successfully mimicked lung alveoli in structure and cellular responses after gemcitabine treatment were similar to clinical regimen of treating lung carcinoma. The microbubble scaffold is promising to facilitate anticancer drug discovery by providing more accurate preclinical predictions.
2157 related Products with: The preparation of cell-containing microbubble scaffolds to mimic alveoli structure as 3D drug screening system for lung cancer.Caspase 2 Inhibitor Drug Caspase 10 Inhibitor Drug Non small cell lung carci HDAC Inhibitor Drug Scree Non small cell lung carci Multiple lung carcinoma ( Caspase 7 Inhibitor Drug PLTP Inhibitor Drug Scree Caspase 4 Inhibitor Drug Cell Meter™ Fluorimetri MarkerGeneTM Fluorescent MarkerGeneTM Long Wavelen
#32084535 // Save this To Up
Oral gallic acid improve liver steatosis and metabolism modulating hepatic lipogenic markers in obese mice.Gallic acid (GA) is a natural endogenous polyphenol found in a variety of fruits, vegetables and wines, with beneficial effects on the energetic homeostasis.
1552 related Products with: Oral gallic acid improve liver steatosis and metabolism modulating hepatic lipogenic markers in obese mice.11 (4,4 difluoro 5,7 dime Liver cancer tissue array Liver disease spectrum ti Liver tissue, type B hepa Colon cancer, metastasize Liver cancer test tissue Breast cancer tissue arra Gallic acid monohydrate C Rabbit Anti-IAA (Indole-3 Phenethyl 1 thio beta D g Oral cavity squamous cell Rabbit Anti-IAA (Indole-3
#32084501 // Save this To Up
Megestrol Acetate Induced Proliferation and Differentiation of Osteoblastic MC3T3-E1 Cells: A Drug Repurposing Approach.Drug repurposing or repositioning i.e; identifying new indications for existing drugs have recently accelerate the process of drug development and discovery. Megestrol acetate (1) is a well-known progestin. It is commonly used as an appetite stimulant, and also in the treatment of breast, and endometrial cancer. The aim of this study is to investigate the effect of megestrol acetate (1) in osteoblast differentiation, and to determine the possible mechanism involved in megestrol acetate (1) induced osteoblast differentiation.
1093 related Products with: Megestrol Acetate Induced Proliferation and Differentiation of Osteoblastic MC3T3-E1 Cells: A Drug Repurposing Approach.
#32084391 // Save this To Up
NLRP10 ablation protects against ischemia/reperfusion-associated brain injury by suppression of neuroinflammation.Ischemic stroke leads to neuronal cell death and induces a cascade of inflammatory signals that results in secondary brain damage. Although constant efforts to develop therapeutic strategies and to reveal the molecular mechanism resulting in the physiopathology of this disease, much still remains unclear. Membrane-bound Toll-like receptors (TLRs) and cytosolic nucleotide binding oligomerization domain (NOD)-like receptors (NLRs) are two major families of pattern recognition receptors that initiate pro-inflammatory signaling pathways. In the present study, we explored the role of NLRP10 in regulating inﬂammatory responses in acute ischemic stroke using the wild type (WT) and NLRP10 knockout (KO) mice by inducing middle cerebral artery occlusion/reperfusion (MCAO) injuries. The study first showed that NLRP10 was over-expressed in the ischemic penumbra of WT mice. Then, the brain infarct volume was significantly decreased, and the moving activity was improved post-MCAO in mice with NLRP10 knockout. Apoptosis was also alleviated by NLRP10-knockout, as evidenced by the decreased number of TUNEL-staining cells. Further, NLRP10 deficiency attenuated the activation of glia cells in hippocampus of mice with MCAO operation. NLRP10 inhibition ameliorated the levels of inflammatory factors in peripheral blood serum and hippocampus of mice after stroke. The activation of toll-like receptor (TLR)-4/nuclear factor-κB (NF-κB) signaling pathways was markedly suppressed by NLRP10 ablation in mice after MCAO treatment. Importantly, inflammasome, including NLRP12, ASC and Caspase-1, induced by MCAO in hippocampus of mice was clearly impeded by the loss of NLRP10. The results above were mainly verified in LPS-incubated astrocytes in the absence of NLRP10. Correspondingly, in LPS-treated astrocytes, NLRP10 knockout-reduced inflammation via impairing TLR-4/NF-κB and NLRP12/ASC/Caspase-1 pathways was evidently restored by over-expressing NLRP10. Therefore, the results above indicated an essential role of NLRP10 in regulating ischemic stroke, presenting NLRP10 as a promising target to protect human against stroke.
2541 related Products with: NLRP10 ablation protects against ischemia/reperfusion-associated brain injury by suppression of neuroinflammation.Brain disease spectrum (b Multiple brain cancer and Multiple brain cancer tis Brain tumor tissue array Ofloxacin CAS Number [824 Brain cancer test tissue Human Brain Derived Neuro Anti-Human Brain-Derived Anti 3 DG imidazolone Mon Brain Natriuretic Peptide Brain glioblastoma tissue In vitro Human Brain Micr
#32084370 // Save this To Up
Knockdown of long non-coding RNAs of maternally expressed 3 (lncRNA-MEG3) alleviates hyperoxia-induced lung injury via inhibiting thioredoxin-interacting protein (TXNIP)-mediated pyroptosis by binding to microRNA miR-18a.Long-term hyperoxia exposure may cause lung damage, with characteristic inflammation. Long non-coding RNA of maternally expressed 3 (lncRNA-MEG3) is up-regulated in lung tissues exposed to hyperoxia; however, the underlying mechanism is unclear. Hyperoxia-induced cells and mouse models were used to study these mechanisms. Molecular assays were used to detect cell viability, cytotoxicity, and expression of microRNA miR-18a, MEG3, and inflammatory cytokines. The interaction among MEG3, miR-18a, and thioredoxin-interacting protein (TXNIP) was verified and pyroptosis-related proteins analyzed. The in vivo model was established by exposing MEG3 knockdown mice to hyperoxia. Hemotoxylin and eosin staining was used to assess pathological alterations of lung tissues. Hyperoxia suppressed cell viability, induced cell damage, and exacerbated the secretion of interleukin IL1B and IL18. Hyperoxia inhibited miR-18a, with increased expression of MEG3, TXNIP, and NOD-like receptor family pyrin domain containing 3 (NLRP3). MEG3 aggravated TXNIP expression by binding to miR-18a. Knockdown of MEG3 rescued hyperoxia-induced pyroptosis by up-regulating miR-18a. Furthermore, knockdown of MEG3 inhibited NLRP3 inflammasome activity and caspase-1 signaling by miR-18a. In vivo knockdown of MEG3 and overexpression of miR-18a relieved hyperoxia-induced lung injury via restraining NLRP3 inflammasome-mediated pyroptosis, whereas miR-18a inhibition reversed these effects. In conclusion, knockdown of MEG3 inhibits pyroptosis to alleviate hyperoxia lung injury by suppressing NLRP3 inflammasome and caspase-1 signaling via regulating miR-18a-TXNIP axis.
2127 related Products with: Knockdown of long non-coding RNAs of maternally expressed 3 (lncRNA-MEG3) alleviates hyperoxia-induced lung injury via inhibiting thioredoxin-interacting protein (TXNIP)-mediated pyroptosis by binding to microRNA miR-18a.Recombinant Human IFN-alp Rabbit Anti-Human Toll In Recombinant Human IFN-alp Native Parainfluenza 3Ant Rabbit Anti-APIP Apaf1 In Rat Retinol Binding Prote Recombinant HIV-1 gp41 Lo 1,6-Anhydro-2-O-p-toluene Rat monoclonal anti mouse Rabbit Anti-APIP Apaf1 In Rat Tissue Lysate (total Recombinant Human S100B C
#32084325 // Save this To Up
Mural Cell SDF1 Signaling is Associated with the Pathogenesis of Pulmonary Arterial Hypertension.Pulmonary artery smooth muscle cells (PASMCs) and pericytes are NG2+ mural cells that provide structural support to pulmonary arteries and capillaries. In pulmonary arterial hypertension (PAH), both mural cell types contribute to PA muscularization but whether similar mechanisms are responsible for their behavior is unknown.
2202 related Products with: Mural Cell SDF1 Signaling is Associated with the Pathogenesis of Pulmonary Arterial Hypertension.
#32084267 // Save this To Up
The Role of Autophagy in the Innate Immune Response to Fungal Keratitis Caused by Aspergillus fumigatus Infection.To determine the role of autophagy in the innate immune response to fungal keratitis (FK) caused by Aspergillus fumigatus infection.
2889 related Products with: The Role of Autophagy in the Innate Immune Response to Fungal Keratitis Caused by Aspergillus fumigatus Infection.FDA Standard Frozen Tissu FDA Standard Frozen Tissu FDA Standard Frozen Tissu FDA Standard Frozen Tissu MultiGene Gradient therm Multiple organ tumor tiss Anti beta3 AR Human, Poly Thermal Shaker with cooli FDA Standard Frozen Tissu FDA Standard Frozen Tissu Infection diseases: Heli TCP-1 theta antibody Sour
#32084217 // Save this To Up
The role of Glial cell derived neurotrophic factor in head and neck cancer.Glial cell-derived neurotrophic factor (GDNF) is reported to promote the survival of neurons and salivary gland regeneration after radiation damage. This study investigated the effect of GDNF on cell migration, growth, and response to radiation in preclinical models of head and neck squamous cell carcinoma (HNSCC) and correlated GDNF expression to treatment outcomes in HNSCC patients. Our ultimate goal is to determine whether systemic administration of GDNF at high dose is safe for the management of hyposalivation or xerostomia in HNSCC patients. Three HPV-positive and three HPV-negative cell lines were examined for cell migration, growth, and clonogenic survival in vitro and tumor growth assay in vivo. Immunohistochemical staining of GDNF, its receptors GFRα1 and its co-receptor RET was performed on two independent HNSCC tissue microarrays (TMA) and correlated to treatment outcomes. Results showed that GDNF only enhanced cell migration in two HPV-positive cells at supra-physiologic doses, but not in HPV-negative cells. GDNF did not increase cell survival in the tested cell lines post-irradiation. Likewise, GDNF treatment affected neither tumor growth in vitro nor response to radiation in xenografts in two HPV-positive and two HPV-negative HNSCC models. High stromal expression of GDNF protein was associated with worse overall survival in HPV-negative HNSCC on multivariate analysis in a combined cohort of patients from Stanford University (n = 82) and Washington University (n = 189); however, the association between GDNF gene expression and worse survival was not confirmed in a separate group of HPV-negative HNSCC patients identified from the Cancer Genome Atlas (TCGA) database. Based on these data, we do not believe that GNDF is a safe systemic treatment to prevent or treat xerostomia in HNSCC and a local delivery approach such as intraglandular injection needs to be explored.
2346 related Products with: The role of Glial cell derived neurotrophic factor in head and neck cancer.Multiple head and neck ca Head & Neck cancer test t Head and neck cancer tiss Head and neck squamous ca Multiple head and neck ca Head and neck cancer tiss Human Glial Derived Neuro Head & Neck cancer tissue Human Stromal Cell-Derive Multiple Head & Neck canc Lung non small cell cance Monoclonal Anti Brain der
#32084130 // Save this To Up
Graph-based description of tertiary lymphoid organs at single-cell level.Our aim is to complement observer-dependent approaches of immune cell evaluation in microscopy images with reproducible measures for spatial composition of lymphocytic infiltrates. Analyzing such patterns of inflammation is becoming increasingly important for therapeutic decisions, for example in transplantation medicine or cancer immunology. We developed a graph-based assessment of lymphocyte clustering in full whole slide images. Based on cell coordinates detected in the full image, a Delaunay triangulation and distance criteria are used to build neighborhood graphs. The composition of nodes and edges are used for classification, e.g. using a support vector machine. We describe the variability of these infiltrates on CD3/CD20 duplex staining in renal biopsies of long-term functioning allografts, in breast cancer cases, and in lung tissue of cystic fibrosis patients. The assessment includes automated cell detection, identification of regions of interest, and classification of lymphocytic clusters according to their degree of organization. We propose a neighborhood feature which considers the occurrence of edges with a certain type in the graph to distinguish between phenotypically different immune infiltrates. Our work addresses a medical need and provides a scalable framework that can be easily adjusted to the requirements of different research questions.
1409 related Products with: Graph-based description of tertiary lymphoid organs at single-cell level.Human Phospho-EGFR (Y1068 Human Mouse Rat Phospho-S Single Donor Human Atopic Human Beta-cell Attractin Human Mouse Rat Phospho-p MarkerGeneTM Fluorescent Human Mouse Rat Phospho-E Human Phospho-Stat 5 (Y69 Human Mouse Rat Phospho-E Human Mouse Phospho-Stat Single Donor Human Atopic Human Mouse Rat Phospho-T
#32084123 // Save this To Up
Overexpression of Bone Morphogenetic Protein-1 Promotes Osteogenesis of Bone Marrow Mesenchymal Stem Cells In Vitro.BACKGROUND Osteogenesis of bone marrow mesenchymal stem cells (BMSCs) is an important research topic in the application of bone tissue engineering. Bone morphogenetic protein-1 (BMP-1) is important in bone formation and stability, but its effects on the osteogenesis of BMSCs are unclear. This study aimed to investigate the association of BMP-1 with the osteogenic capacity of BMSCs. MATERIAL AND METHODS Primary rabbit BMSCs were cultured and divided into a BMP-1-overexpressing group, a Green Fluorescent Protein-expressing (GFP) group, and a Control group. The transfection efficiency of BMP-1 was tested by Western blotting. Cell viabilities, alkaline phosphatase (ALP) activities, Ca2+ concentrations, and gross examinations of BMSC sheets were examined at different times. The osteogenic marker collagen I was assessed by immunohistochemical analysis. RESULTS The cell viability, ALP activity, and Ca2+ content of the BMP1-overexpressed group were significantly enhanced compared with the GFP group and Control group. Immunohistochemistry staining results showed that BMP-1 promoted the expression of type I collagen in BMSCs sheets. CONCLUSIONS Our results suggest that the overexpression of BMP-1 can promote the osteogenesis of BMSCs and provides an improved method of cell-based tissue engineering.
1997 related Products with: Overexpression of Bone Morphogenetic Protein-1 Promotes Osteogenesis of Bone Marrow Mesenchymal Stem Cells In Vitro.Anti-Bone Morphogenetic P Anti-Bone Morphogenetic P Anti-Bone Morphogenetic P Bone Morphogenetic Protei Bone Morphogenetic Protei Monoclonal Anti Bone Morp Monoclonal Anti Bone Morp Anti-Bone Morphogenetic P Bone Morphogenetic Protei Anti-Bone Morphogenetic P Monoclonal Anti-Bone Morp Anti Bone Morphogenetic P
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45 Fax 0032 16 50 90 45
9, rue Lagrange, 75005 Paris
Tel 01 43 25 01 50 Fax 01 43 25 01 60
52062 Aachen Deutschland
Tel 0241 40 08 90 86 Fax 0241 55 91 05 36
Howard Frank Turnberry House
1404-1410 High Road
Whetstone London N20 9BH
Tel 020 3393 8531 Fax 020 8445 9411
Schweiz Züri +41435006251
Česká republika Praha +420246019719
Ireland Dublin +35316526556
Norge Oslo +4721031366
Finland Helsset +358942419041
Sverige Stockholm +46852503438
Ελλάς Αθήνα +302111768494
Magyarország Budapest +3619980547
GENTAUR Poland Sp. z o.o.
ul. Grunwaldzka 88/A m.2
81-771 Sopot, Poland
Tel 058 710 33 44
Fax 058 710 33 48
GENTAUR Nederland BV
5521 DG Eersel Nederland
Tel 0208-080893 Fax 0497-517897
Piazza Giacomo Matteotti, 6, 24122 Bergamo
Tel 02 36 00 65 93 Fax 02 36 00 65 94
53 Iskar Str. 1191 Kokalyane, Sofia